Vanguard Global Advisers’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.79M Sell
171,319
-4,016
-2% -$44.8K ﹤0.01% 1335
2026
Q1
$2.09M Buy
+175,335
New +$1.79M ﹤0.01% 1165

Other funds holding AHCO

Vanguard Global Advisers's AHCO Position: Q2 2026 in Review

Vanguard Global Advisers reduced its AdaptHealth (AHCO) stake by 2.3% in Q2 2026, selling an estimated $44.8K and leaving 171,319 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1335.

Vanguard Global Advisers first reported a position in AHCO in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.09M in Q1 2026. 232 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Vanguard Global Advisers held 171,319 shares of AdaptHealth worth $1.79M as of Q2 2026.
  • Vanguard Global Advisers sold 4,016 AdaptHealth shares in Q2 2026, an estimated $44.8K.
  • AdaptHealth made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #1335 holding.
  • Vanguard Global Advisers first reported a position in AdaptHealth in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's AdaptHealth position peaked at $2.09M in Q1 2026.
  • 232 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.